Drug
LY3410738
LY3410738 is a pharmaceutical drug with 5 clinical trials. Currently 2 active trials ongoing. Historical success rate of 66.7%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
66.7%
Based on 2 completed trials
Completion Rate
67%(2/3)
Active Trials
2(40%)
Results Posted
0%(0 trials)
Terminated
1(20%)
Phase Distribution
Ph phase_1
5
100%
Phase Distribution
5
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
5(100.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
66.7%
2 of 3 finished
Non-Completion Rate
33.3%
1 ended early
Currently Active
2
trials recruiting
Total Trials
5
all time
Status Distribution
Active(2)
Completed(2)
Terminated(1)
Detailed Status
Active, not recruiting2
Completed2
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
2
Success Rate
66.7%
Most Advanced
Phase 1
Trials by Phase
Phase 15 (100.0%)
Trials by Status
active_not_recruiting240%
terminated120%
completed240%
Recent Activity
2 active trials
Showing 5 of 5
active_not_recruitingphase_1
Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations
NCT04521686
active_not_recruitingphase_1
Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 Mutations
NCT04603001
completedphase_1
A Study Comparing Different Formulations of LY3410738 in Healthy Adult Participants
NCT06181084
completedphase_1
A Study of LY3410738 in Healthy Adult Participants
NCT06181045
terminatedphase_1
Study of the Effects of Itraconazole and Carbamazepine on LY3410738 in Healthy Participants
NCT05205447
Clinical Trials (5)
Showing 5 of 5 trials
NCT04521686Phase 1
Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations
NCT04603001Phase 1
Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 Mutations
NCT06181084Phase 1
A Study Comparing Different Formulations of LY3410738 in Healthy Adult Participants
NCT06181045Phase 1
A Study of LY3410738 in Healthy Adult Participants
NCT05205447Phase 1
Study of the Effects of Itraconazole and Carbamazepine on LY3410738 in Healthy Participants
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5